VivoPower Receives Nasdaq Letter Confirming it is in Compliance with Nasdaq Listing Standard

Stock Information for TRACON Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TRACON Pharmaceuticals Inc.

VivoPower Commences $29 Million Shareholder Loan Financing Retirement Plan
VivoPower Believes It Meets Nasdaq Equity Requirement Following Reg S Investment
VivoPower Confirms Record Date for Special Dividend Eligibility for Caret Digital Spin Off
VivoPower Closes First Phase of US$121 Million Private Placement
Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings
VivoPower Advances US$308 Million Direct NASDAQ Spin-Off of Caret Digital
VivoPower Announces Key Leadership Recruits
VivoPower and Flare Launch Definitive Strategic Partnership to Deploy US$100 Million in XRP for Institutional Yield

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.